The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Saunders Michael E since year 2005.
The trader's CIK number is 1308926.
At the time of this reporting, Saunders Michael E is the VP, Clinical Develop of Allos Therapeutics Inc .
(stock ticker symbol ALTH).
See this page for all insider trading activities at Allos Therapeutics Inc .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2006-12-29||ALTH||Allos Therapeutics Inc||Buy||2,500||1.82||4,547|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Saunders Michael E (VP, Clinical Develop of Allos Therapeutics Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.